Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: NECROSIS-FACTOR-ALPHA ; NATURAL-KILLER-CELLS ; HUMAN DENDRITIC CELLS ; TOLL-LIKE RECEPTORS ; COLONY-STIMULATING FACTOR ; ISOLATED LIMB PERFUSION ; REGULATORY T-CELLS ; PHASE-I TRIAL ; DEPENDENT CELLULAR CYTOTOXICITY ; IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES
    Abstract: During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for use in cancer patients, and many others are being investigated as standalone therapeutic interventions or combined with conventional treatments in clinical studies. Immunotherapies may be subdivided into "passive" and "active" based on their ability to engage the host immune system against cancer. Since the anticancer activity of most passive immunotherapeutics (including tumor-targeting monoclonal antibodies) also relies on the host immune system, this classification does not properly reflect the complexity of the drug-host-tumor interaction. Alternatively, anticancer immunotherapeutics can be classified according to their antigen specificity. While some immunotherapies specifically target one (or a few) defined tumor-associated antigen(s), others operate in a relatively non-specific manner and boost natural or therapy-elicited anticancer immune responses of unknown and often broad specificity. Here, we propose a critical, integrated classification of anticancer immunotherapies and discuss the clinical relevance of these approaches.
    Type of Publication: Journal article published
    PubMed ID: 25537519
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CELLS ; EXPRESSION ; SURVIVAL ; CELL ; human ; IN-VIVO ; EXPOSURE ; MORTALITY ; MICE ; ACTIVATION ; RESPONSES ; INFECTION ; MECHANISM ; DENDRITIC CELLS ; IMMUNE-RESPONSES ; virus ; NO ; HEALTH ; HUMANS ; antigen presentation ; INDIVIDUALS ; immune response ; IMMUNE-RESPONSE ; INFLAMMATORY RESPONSES ; SUPPRESSOR ; elderly ; USA ; ENGLAND ; EXPANSION ; NATURAL-KILLER ; PUBLIC-HEALTH ; MEDICINE ; IFN-GAMMA PRODUCTION ; outcome ; response ; ALPHA-GALACTOSYLCERAMIDE ; Crosstalk ; INNATE IMMUNE-RESPONSE ; KILLER T-CELLS ; MURINE CYTOMEGALOVIRUS ; Myeloid cell ; myeloid cells ; myeloid-derived suppressor cells ; SUPPRESSOR-CELLS ; TUMOR IMMUNOSURVEILLANCE
    Abstract: infection with influenza A virus (IAV) presents a substantial threat to public health worldwide, with young, elderly, and immunodeficient individuals being particularly susceptible. Inflammatory responses play an important role in the fatal outcome of IAV infection, but the mechanism remains unclear. We demonstrate here that the absence of invariant NKT (iNKT) cells in mice during IAV infection resulted in the expansion of myeloid-derived suppressor cells (MDSCs), which suppressed IAV-specific immune responses through the expression of both arginase and NOS, resulting in high IAV titer and increased mortality. Adoptive transfer of iNKT cells abolished the suppressive activity of MDSCs, restored IAV-specific immune responses, reduced IAV titer, and increased survival rate. The crosstalk between iNKT and MDSCs was CD1d- and CD40-dependent. Furthermore, IAV infection and exposure to TLR agonists relieved the suppressive activity of MDSCs. Finally, we extended these results to humans by demonstrating the presence of myeloid cells with suppressive activity in the PBLs of individuals infected with IAV and showed that their suppressive activity is substantially reduced by iNKT cell activation. These findings identify what we believe to be a novel immunomodulatory role of iNKT cells, which we suggest could be harnessed to abolish the immunosuppressive activity of MDSCs during IAV infection
    Type of Publication: Journal article published
    PubMed ID: 19033672
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: RECEPTOR ; CELLS ; CELL ; KINASE ; SITE ; MOLECULES ; TRANSDUCTION ; ACTIVATION ; COMPLEX ; COMPLEXES ; ANTIGEN ; T-CELL ; T-CELLS ; BINDING ; PHOSPHORYLATION ; signal transduction ; MHC ; SIGNAL-TRANSDUCTION ; DEGRADATION ; IMMUNITY ; LIPID RAFTS ; REVEALS ; NAIVE ; RECEPTORS ; signaling ; monitoring ; TECHNOLOGY ; immunology ; SRC-FAMILY KINASES ; MAINTENANCE ; CD4 RECEPTOR ; IMMUNE ; CATALYTIC-ACTIVITY ; PROTEIN-TYROSINE KINASE
    Abstract: T cell antigen receptor (TCR) and coreceptor ligation is thought to initiate signal transduction by inducing activation of the kinase Lck. Here we showed that catalytically active Lck was present in unstimulated naive T cells and thymocytes and was readily detectable in these cells in lymphoid organs. In naive T cells up to similar to 40% of total Lck was constitutively activated, part of which was also phosphorylated on the C-terminal inhibitory site. Formation of activated Lck was independent of TCR and coreceptors but required Lck catalytic activity and its maintenance relied on monitoring by the HSP90-CDC37 chaperone complex to avoid degradation. The amount of activated Lck did not change after TCR and coreceptor engagement; however it determined the extent of TCR-zeta phosphorylation. Our findings suggest a dynamic regulation of Lck activity that can be promptly utilized to initiate T cell activation and have implications for signaling by other immune receptors
    Type of Publication: Journal article published
    PubMed ID: 20541955
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...